Literature DB >> 9556704

Prader-Willi and Angelman syndromes. Disorders of genomic imprinting.

S B Cassidy1, S Schwartz.   

Abstract

Prader-Willi and Angelman syndromes are 2 clinically distinct disorders associated with multiple anomalies and mental retardation. They are only discussed together because they share a similar and uncommon genetic basis: they involve genes that are located in the same region in the genome and are characterized by genetic imprinting. This normal process has contributed to these 2 complex and severe conditions through inactivation of 1 copy of the genes relevant to each disorder: the maternally derived copy of genes for Prader-Willi syndrome in proximal 15q are normally silent, and a paternally derived copy of 1 gene for Angelman syndrome in 15q is normally silent. For both disorders, when the normally active copy of the gene or genes is missing, abnormality results. Since the genes for these 2 disorders are located very close together, and since the center involved in inactivating the genes involved in imprinting may be the same, both these disorders usually result from the same chromosomal deletion; which disorder results depends on the parent of origin of the chromosome 15 that becomes deleted. Both Prader-Willi and Angelman syndrome can also occur as a result of having both members of the chromosome 15 pair derived from 1 parent, a condition known as uniparental disomy. Both can also result from a structural abnormality of the imprinting center, known as an imprinting mutation. In addition, Angelman syndrome can be caused by a mutation in the gene that causes it; a comparable cause is not present in Prader-Willi syndrome since it results from abnormality in more than 1 gene. Finally, despite the complexity of possible causes, all but the single gene mutation of the Angelman syndrome gene can be detected through methylation-sensitive DNA probes, since DNA methylation is the process by which the genes for these 2 disorders are imprinted. This unusual property of specific areas of the DNA holds promise for future treatment of these and other disorders related to imprinting through reversal of the imprinting process.

Entities:  

Mesh:

Year:  1998        PMID: 9556704     DOI: 10.1097/00005792-199803000-00005

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  24 in total

Review 1.  Growth hormone therapy in the Prader-Willi syndrome.

Authors:  W F Paterson; M D C Donaldson
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

Review 2.  Evolutionary medicine: its scope, interest and potential.

Authors:  Stephen C Stearns
Journal:  Proc Biol Sci       Date:  2012-08-29       Impact factor: 5.349

Review 3.  Mouse chromosome engineering for modeling human disease.

Authors:  Louise van der Weyden; Allan Bradley
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

Review 4.  Genetic, epigenetic, and environmental contributions to neural tube closure.

Authors:  Jonathan J Wilde; Juliette R Petersen; Lee Niswander
Journal:  Annu Rev Genet       Date:  2014-10-06       Impact factor: 16.830

5.  Epidermolysis bullosa simplex associated with pyloric atresia is a novel clinical subtype caused by mutations in the plectin gene (PLEC1).

Authors:  Hiroyuki Nakamura; Daisuke Sawamura; Maki Goto; Hideki Nakamura; James R McMillan; Susam Park; Sumio Kono; Shiro Hasegawa; Son'e Paku; Tomohiko Nakamura; Yoshihumi Ogiso; Hiroshi Shimizu
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

Review 6.  Complex and segmental uniparental disomy (UPD): review and lessons from rare chromosomal complements.

Authors:  D Kotzot
Journal:  J Med Genet       Date:  2001-08       Impact factor: 6.318

7.  A preliminary analysis of the phenomenology of skin-picking in Prader-Willi syndrome.

Authors:  Jessica R Morgan; Eric A Storch; Douglas W Woods; Danielle Bodzin; Adam B Lewin; Tanya K Murphy
Journal:  Child Psychiatry Hum Dev       Date:  2010-08

8.  Prader-Willi Syndrome: Clinical and Genetic Findings.

Authors:  Merlin G Butler; Travis Thompson
Journal:  Endocrinologist       Date:  2000-07

9.  Clinical management of behavioral characteristics of Prader-Willi syndrome.

Authors:  Alan Y Ho; Anastasia Dimitropoulos
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 10.  Molecular basis of genetic neuropsychiatric disorders.

Authors:  Deepa V Venkitaramani; Paul J Lombroso
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.